Literature DB >> 1362404

Surgical treatment of the endocrine pancreas and Zollinger-Ellison syndrome in the MEN 1 syndrome.

N W Thompson1.   

Abstract

Islet cell neoplasia is a frequent occurrence in multiple endocrine neoplasia type 1 (MEN 1). Sixteen of 27 patients with MEN 1 developed functioning endocrine pancreatic tumor syndromes. Eleven of the 16 developed Zollinger-Ellison syndrome and each was evaluated by a combination of computed tomography and hepatic angiography to exclude hepatic metastasis and percutaneous transhepatic catheterization to localize the tumor. Seven of the 11 patients were found to have duodenal gastrinomas with multiple duodenal tumors in three patients. Four of the 11 patients had only pancreatic gastrinomas. In addition to the gastrinomas, other types of islet tumors in the pancreatic body or tail were found in nine of the 11 patients. None of the patients had hepatic metastases. Seven of the 11 patients were treated by distal pancreatectomy and since 1986 all patients have had duodenotomies as part of the surgical exploration. Postsurgical evaluation ranging from three months to 14 years indicates that 10 of 11 patients have normal basal gastrin levels. We conclude that duodenal gastrinomas are common in MEN 1 and can be managed successfully by appropriate operative intervention.

Entities:  

Mesh:

Year:  1992        PMID: 1362404

Source DB:  PubMed          Journal:  Henry Ford Hosp Med J        ISSN: 0018-0416


  9 in total

1.  Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias.

Authors:  Francesco Tonelli; Geri Fratini; Gabriella Nesi; Maria Silvia Tommasi; Giacomo Batignani; Alberto Falchetti; Maria Luisa Brandi
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

Review 2.  Care for patients with multiple endocrine neoplasia type 1: the current evidence base.

Authors:  C R C Pieterman; M R Vriens; K M A Dreijerink; R B van der Luijt; G D Valk
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

Review 3.  Optimal treatment of Zollinger-Ellison syndrome and related conditions in elderly patients.

Authors:  Paola Tomassetti; Teresa Salomone; Marina Migliori; Davide Campana; Roberto Corinaldesi
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 4.  Biliary tree gastrinomas in multiple endocrine neoplasia type 1 syndrome.

Authors:  Francesco Tonelli; Francesco Giudici; Gabriella Nesi; Giacomo Batignani; Maria Luisa Brandi
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

5.  Surgical management of insulinoma associated with multiple endocrine neoplasia type I.

Authors:  D S O'Riordain; T O'Brien; J A van Heerden; F J Service; C S Grant
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

Review 6.  Multiple endocrine neoplasia type 1 (MEN 1) revisited.

Authors:  B Padberg; S Schröder; C Capella; A Frilling; G Klöppel; P U Heitz
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 7.  The effect of Zollinger-Ellison syndrome and neuropeptide-secreting tumors on the stomach.

Authors:  J R Pisegna
Journal:  Curr Gastroenterol Rep       Date:  1999-12

Review 8.  Unusual functioning endocrine tumors.

Authors:  Chandrajit P Raut; Jeffrey E Lee
Journal:  Curr Treat Options Oncol       Date:  2004-08

9.  The current strategy for managing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1.

Authors:  Yusuke Niina; Nao Fujimori; Taichi Nakamura; Hisato Igarashi; Takamasa Oono; Kazuhiko Nakamura; Masaki Kato; Robert T Jensen; Tetsuhide Ito; Ryoichi Takayanagi
Journal:  Gut Liver       Date:  2012-01-19       Impact factor: 4.519

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.